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Research
Worldwide use of chemically stable poly­
brominated diphenyl ethers (PBDEs) as 
flame retardants in consumer products has 
increased since the 1970s (Costa et al. 2008). 
Levels of PBDEs in the environment (Hale 
et al. 2003; Law et al. 2006; Oros et al. 2005) 
and tissues of invertebrates, fish, birds, and 
mammals have increased in the last 30 years 
(Yogui and Sericano 2009). In humans, 
PBDEs have been detected in numerous tis­
sues, with serum concentrations reported as 
high as 50 ng/g lipid (Petreas et al. 2003). 
PBDE concentrations in breast milk dou­
bled every 5 years between 1972 and 1997 
(Rahman et al. 2001; She et al. 2007). The 
predominant routes of exposure are diet and 
inhalation (Allen et al. 2007; Costa et al. 
2008; Rose et al. 2010; Schecter et al. 2005). 
PBDEs with less than five bromine substitu­
tions, such as 2,2´,4,4´­tetrabromo  diphenyl 
ether (BDE­47) and 2,2´,4,4´,5­pentabromo­
diphenyl ether (BDE­99), have attracted the 
greatest concern because they show the great­
est bio  accumula  tion (Darnerud et al. 2001) 
and can be formed by debromina  tion of high­
er­substituted PBDEs (Gerecke et al. 2005; 
Stapleton et al. 2006; Stapleton and Dodder 
2008).
PBDEs share structural similarities to 
a subset of the polychlorinated biphenyls 
(PCBs) that have more than one chloro­sub­
stituent in the ortho position, in particu  lar, 
non  coplanarity of their phenyl rings. Like the 
ortho­substituted PCBs (Denison and Nagy 
2003; Van den Berg et al. 2006), PBDEs 
(Peters et al. 2004) have very weak or negli­
gible activity at the aryl hydro  carbon recep­
tor, but disrupt calcium ion (Ca2+) signaling 
in several cell types (Dingemans et al. 2008, 
2010). One mechanism by which ortho-
substituted PCBs disrupt Ca2+ signaling and 
contribute to neuro  toxicity is via inter  actions 
with ryanodine receptors (RyRs) (Pessah 
et al. 2010; Wong and Pessah 1996). For 
example, 2,2´,3,5´,6­pentachloro  biphenyl 
(PCB­95) at nano  molar concentrations sen­
sitizes RyR Ca2+ channels in rat hippocam­
pal microsomal preparations (Pessah et al. 
2010; Wong et al. 1997a), and alters neuro­
plasticity in rat hippocampal slices (Kim 
et al. 2009). Developmental exposure to 
PCB­95 or Aroclor 1254 results in behavioral 
abnormalities in rats and altered patterns of 
RyR expression in brain (Schantz et al. 1997; 
Wong et al. 1997b; Yang et al. 2009). In rats 
exposed peri  natally, PCB­95 alters the balance 
of excitatory/inhibitory currents and disrupts 
the tono  topic map of the primary auditory 
cortex (Kenet et al. 2007). Identification of 
RyRs as a relevant molecular target in PCB 
neuro  toxicity may be generalized to related 
non  coplanar persistent organic pollutants 
such as PBDEs. Evidence of a convergent 
mechanism by which PCBs and PBDEs 
dys  regu  late RyRs would be of toxicological 
significance considering that these tightly 
regulated Ca2+ channels reside within spe­
cialized regions of sarcoplasmic/endoplasmic 
reticulum (SR/ER) membranes where they 
contribute to and regulate essential aspects of 
Ca2+ signaling (Pessah et al. 2010).
In the present study we examined the 
structure–activity relationship (SAR) of 
PBDEs and their metabolites toward the 
two major RyR isoforms found in the brain 
and striated muscle (RyR1 and RyR2). Our 
findings indicate that PBDEs are potent 
modulators of both RyR isoforms. Para­ and 
ortho­substitutions are a key structural deter­
minant of this activity and are predictive of 
their neurotoxicity.
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Ba c k g r o u n d: Polybrominated diphenyl ethers (PBDEs) are widely used flame retardants that 
bioaccumulate in human tissues. Their neurotoxicity involves dysregulation of calcium ion (Ca2+) 
signaling; however, specific mechanisms have yet to be defined.
oB j e c t i v e: We aimed to define the structure–activity relationship (SAR) for PBDEs and their 
metabolites toward ryanodine receptors type 1 (RyR1) and type 2 (RyR2) and to determine whether 
it predicts neurotoxicity.
Me t h o d s : We analyzed [3H]ryanodine binding, microsomal Ca2+ fluxes, cellular measurements of 
Ca2+ homeo  stasis, and neurotoxicity to define mechanisms and specificity of PBDE-mediated Ca2+ 
dysregulation.
re s u l t s: PBDEs possessing two ortho-bromine substituents and lacking at least one para-bromine 
substituent (e.g., BDE-49) activate RyR1 and RyR2 with greater efficacy than corresponding conge-
ners with two para-bromine substitutions (e.g., BDE-47). Addition of a methoxy group in the free 
para position reduces the activity of parent PBDEs. The hydroxylated BDEs 6-OH-BDE-47 and 
4´-OH-BDE-49 are biphasic RyR modulators. Pretreatment of HEK293 cells (derived from human 
embryonic kidney cells) expressing either RyR1 or RyR2 with BDE-49 (250 nM) sensitized Ca2+ 
flux triggered by RyR agonists, whereas BDE-47 (250 nM) had negligible activity. The divergent 
activity of BDE-49, BDE-47, and 6-OH-BDE-47 toward RyRs predicted neurotoxicity in cultures 
of cortical neurons.
co n c l u s i o n s: We found that PBDEs are potent modulators of RyR1 and RyR2. A stringent SAR 
at the ortho and para position determined whether a congener enhanced, inhibited, or exerted 
non    monotonic actions toward RyRs. These results identify a convergent molecular target of 
PBDEs previously identified for non  coplanar polychlorinated biphenyls (PCBs) that predicts their 
cellular neuro  toxicity and therefore could be a useful tool in risk assessment of PBDEs and related 
compounds.
key w o r d s : calcium, hydroxylated PBDE, methoxylated PBDE, neurotoxicity, poly  brominated 
biphenyl ether (PBDE), ryanodine receptor (RyR). Environ Health Perspect 119:519–526 
(2011).  doi:10.1289/ehp.1002728 [Online 24 November 2010]Kim et al.
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Materials and Methods
Materials. We purchased neat certified 
2,2´­dibromo  diphenyl ether (BDE­4), 4,4´­
dibromo  diphenyl ether (BDE­15), 2,2´,4­
tribromo  diphenyl ether (BDE­17; 98.4% 
pure), 2,2´,3,4´­tetrabromo  diphenyl ether 
(BDE­42; 100% pure), BDE­47 (100% 
pure), 2,2´,4,5´­tetrabromo  diphenyl ether 
(BDE­49; 100% pure), the hydrox  ylated 
BDEs 6­OH­BDE­47 (98.6% pure) and 
4´­OH­BDE­49 (97.8% pure), and PCB­95 
(99.1 ± 4% pure) from AccuStandard 
(New Haven, CT) and verified purity and   
composition by gas chromatography­
mass spectrometry through the Superfund 
Research Program Analytical Core. Methoxy­
derivatives were provided by Å. Bergman 
(Stockholm University, Stockholm, Sweden).   
[3H]Ryanodine ([3H]Ry, specific activity 
60 Ci/mmol) was obtained from Perkin­
Elmer New England Nuclear (Wilmington, 
DE). 4­Chloro­m­cresol (4­CmC), diphenyl 
ether (DE), rapamycin, and Ca2+ ionophore 
A23187 were purchased from Sigma­Aldrich 
(St. Louis, MO, USA).
Animal use. All animal procedures were 
performed under protocol approved by the 
University of California–Davis Institutional 
Animal Care and Use Committee.
Membrane preparations. Microsomal 
membrane preparations enriched in RyR1 or 
RyR2 were isolated from skeletal muscle and 
heart, respectively, from male New Zealand 
White rabbits (Charles River Laboratories, 
Hollister, CA) as described previously (Mack 
et al. 1992; Zimanyi and Pessah 1991). We 
prepared brain microsomes from mouse neo­
cortical tissue as described previously for the rat 
(Wong et al. 1997a).
[3H]Ry binding assays. We determined 
the amount of specific [3H]Ry binding to 
microsomal membranes in the absence and pres­
ence of PBDE or their metabolites, a measure 
of how RyR activity is affected, as previously 
described (Pessah et al. 2009). See Supplemental 
Material (doi:10.1289/ehp.1002728) for details. 
At least eight concentrations of each congener 
were tested in triplicate in at least three indepen­
dent binding assays. The concentration–response 
curves were analyzed by curve fitting using 
GraphPad Prism Software (version 5; GraphPad 
Software, La Jolla, CA). 
Microsomal Ca2+ flux measurements. 
We measured PBDE­induced release of Ca2+ 
actively accumulated by microsomal vesicles 
in the presence of ATP as previously described 
(Pessah et al. 2006). See Supplemental Material 
(doi:10.1289/ehp.1002728) for details. Initial 
Ca2+ release rates were calculated for at least 
eight PBDE concentrations, including vehicle 
control. The half­maximal rates of Ca2+ release 
(EC50) were determined by curve fitting of 
three experiments. 
Ca2+ imaging of HEK293 cells. We fol­
lowed the method for growing human embry­
onic kidney [human embryonic kidney 293 
(HEK293); RyRnull] cells in culture and the 
protocols for transfection and selection pro­
tocols for HEK293 cells that stably express 
RyR1 (HEK293RyR1) or RyR2 (HEK293RyR2) 
as described previously (Pessah et al. 2009). 
Sixteen hours after introduction of vehicle or 
PBDE, cells were loaded with the Ca2+ indica­
tor Fluo­4 to measure cyto  plasmic Ca2+ changes 
in response to challenges with RyR activa­
tors caffeine or 4­chloro­m­cresol (4­CmC). 
See Supplemental Material (doi:10.1289/
ehp.1002728) for additional details. 
Primary culture of mouse and rat corti-
cal neurons. High­density cultures of corti­
cal neurons were dissociated from post  natal 
day 0–2 Sprague­Dawley rats (Charles River 
Laboratories) for electro  physiological measure­
ments (Yang et al. 2009) or C57BL/6J (B6) 
mice (Charles River Laboratories) for neuronal 
viability measure  ments as previously described 
(Chen et al. 2010). See Supplemental Material 
(doi:10.1289/ehp.1002728) for details.
Multielectrode array (MEA) recording and 
data analysis. MEAs with a central 0.88­mm2 
recording matrix of 64 multi  electrodes (Med­
P545A; AutoMate Scientific, Berkeley, CA) 
were precoated with poly­l­lysine (0.5 mg/mL, 
Sigma Chemical Co., St. Louis, MO) and 
laminin (10 µg/mL, Invitrogen, Carlsbad, 
CA, USA). Dissociated rat cortical cells were 
plated onto the MEAs at a density of 1 × 105 
cells/MEA. Cultures were maintained in 
Neurobasal­A (Invitrogen) supplemented 
with B27 (Invitrogen) as previously described 
(Wayman et al. 2006). Half of the medium was 
replaced twice weekly with fresh Neurobasal­A 
containing B27. At 21 days in vitro, cortical 
neurons grown on MEAs were placed into the 
MED 64CH Integrated Amplifier inter  face 
and spike activity was recorded using Mobius 
software (both from AutoMate Scientific). 
Baseline activity was recorded for 10 min at 
37°C. Cultures were then exposed to vehi­
cle by adding 1 µL DMSO into MEA cul­
tures containing 1 mL culture medium (final 
Figure 1. Ortho-bromines are essential for PBDE activity toward FKBP12-RyR1 complex. Abbreviations: Rap, rapamycin; RR, ruthenium red. (A) Microsomes 
enriched in RyR1 protein were incubated in the presence of either BDE-4 or BDE-15 in [3H]Ry binding buffer. (B) Addition of 20 µM BDE-4 (arrow) to microsomal 
vesicles subsequent to SERCA-dependent Ca2+ accumulation in the presence of ATP (loading phase) resulted in net Ca2+ release. Inhibition of RyR1 by 1µM RR 
blocked the Ca2+ release triggered by BDE-4 (10 µM). (C) Concentration–effect curve for BDE-4–triggered Ca2+ release (EC50 = 9.6 ± 0.2 µM; n = 4). Addition of 
vehicle to the Ca2+-loaded vesicles did not cause Ca2+ release (Vehicle). (D) Concentration-dependent inhibition of BDE-4–enhanced [3H]Ry binding to RyR1 by 
Rap (5 µM BDE-4 with 0–200 µM Rap); Rap alone had negligible effects on [3H]Ry binding to RyR1. n = 3 independent experiments in triplicate. (E) Pretreatment of 
microsomal vesicles with Rap 2 min before loading vesicle with Ca2+ (arrow) inhibited Ca2+ release triggered by subsequent addition (dotted arrow) of 5 µM BDE-4 
but did not inhibit caffeine-induced Ca2+ release. (F) Concentration–effect relationship of Rap inhibition of BDE-4 triggered Ca2+ release; n = 4. 
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0.1% DMSO), and activity was recorded for 
10 min. Subsequently, cultures were exposed 
to either BDE­47 or BDE­49 by adding 1 µL 
1,000× stock solution in DMSO to the well. 
Cultures were sequentially exposed to increas­
ing concentrations of PBDE, and activity was 
recorded for 10 min after each addition. We 
analyzed spontaneous spike activity using the 
Spike Sorting and DC filter applications in 
Mobius. Spikes greater than three times the 
baseline noise were scored. The number of 
spikes per 10­min recording session was deter­
mined (for electrodes showing activity), and 
the mean spike number per MEA was calcu­
lated. Three MEAs from three independent 
dissections were analyzed per PBDE.
Tetrazolium-based MTS assay. We 
performed the MTS [3­(4,5­dimethyl­
thiazol­2­yl)­5­(3­carboxymethoxyphenyl)­2­
(4­sulfophenyl)­2H­tetrazolium] assay to test 
cell viability in cultured mouse cortical neurons 
after 48­hr exposures to BDE­47, BDE­49 or 
6­OH­BDE­47 using the CellTiter 96 Cell 
Proliferation Assay kit (Promega, Madison, 
WI) as previously described (Chen et al. 2010). 
See Supplemental Material (doi:10.1289/
ehp.1002728)  for  additional  details. 
Experiments were performed on three indepen­
dent cultures, with each vehicle or PBDE con­
centration replicated in four wells. Differences 
from vehicle were tested using two­way analysis 
of variance (ANOVA) with post hoc analysis.
Results
Ortho-bromine substitution is required for 
PBDE activity toward RyR1. We first tested 
the minimal structural requirement for PBDE 
activity toward RyR1 using [3H]Ry binding 
analysis to microsomes. Neither unsubstituted 
diphenyl ether nor BDE­15 (< 20 µM) altered 
the amount of specific binding of [3H]Ry to 
RyR1, a meas  ure of receptor activation (Pessah 
et al. 1987). In contrast, BDE­4 significantly 
enhanced specific binding of [3H]Ry to RyR1, 
increasing occupancy 14­fold at 20 µM when 
measured with sub    optimal Ca2+ in the assay 
buffer (Figure 1A). This finding indicates that 
BDE­4 is an efficacious activator of RyR1 
when measured under buffer conditions that 
promote a closed­channel conformation.
Antipyrylazo­III is a low­affinity mem­
brane impermeable dye that allows quantifi­
cation of Ca2+ fluxes across vesicles (Baylor 
et al. 1983). Spectroscopic detection of anti­
pyrylazo­III absorbance measures changes in 
free Ca2+ in the extra  vesicular solution. Ca2+ 
was actively loaded into microsomes via the 
SR/ER Ca2+ ATPase (SERCA) by bolus addi­
tions of Ca2+ to the assay buffer containing 
ATP (Ca2+­loading phase). After the loading 
phase was complete (the dye signal re­estab­
lished baseline), addition of BDE­4 (1–20 µM) 
elicited a net release of Ca2+ (net Ca2+ efflux; 
Figure 1B). The PBDE EC50 value was 
12.0 ± 0.8 µM under conditions that mimic 
the resting state of most mammalian cells (i.e., 
~ 100 nM free Ca2+ at the cyto  plasmic face 
of RyR1). BDE­4–triggered Ca2+ release was 
fully blocked by ruthenium red (RR; 1 µM), 
an RyR blocker (Figure 1B). EC50 values were 
calculated from plots of the initial rate of Ca2+ 
release as a function of BDE­4 concentration 
(Figure 1C). BDE­15 and unsubstituted diphe­
nyl ether at concentrations < 20 µM did not 
elicit detectable release of accumulated Ca2+ in 
the microsomal transport assay (not shown).
Activation of the Ca2+ channel by ortho­
substituted PCBs requires an intact association 
of RyR1 with its accessory protein FK506­
binding protein 12 kDa (FKBP12) (Wong 
and Pessah 1997). Consistent with this 
mecha  nism, enhancement of [3H]Ry binding 
to RyR1 by BDE­4 (5 µM) was inhibited by 
inclusion of rapamycin in the assay (2 min 
pre  incubation) to disrupt the RyR1­FKBP12 
complex (Figure 1D). The importance of the 
FKBP12 complex in mediating the efficacy of 
BDE­4 toward RyR1 was further veri  fied by 
measuring active uptake and release of Ca2+ 
from the same membrane vesicles used for 
[3H]Ry binding analysis. Addition of BDE­4 
(5 µM) to vesicles actively loaded with Ca2+ 
caused release of accumulated Ca2+, and this 
response was inhibited in vesicles pretreated 
with rapamycin in a concentration­dependent 
manner (Figure 1E,F). Rapamycin eliminated 
BDE­4–triggered Ca2+ release without inhibit­
ing caffeine­induced Ca2+ release (Figure 1E), 
indicating that PBDEs sensitize RyR1 via a 
mechanism previously reported for PCBs.
Para substitution of environmentally rele-
vant PBDEs determines RyR1 and RyR2 
activity. Because para­chloro­substitutions of 
PCBs significantly influence activity toward 
RyR1 (Pessah et al. 2006), we investigated 
whether para­bromo­substitutions simi­
larly influence the activity of PBDEs toward 
RyRs, using congeners with higher bromina­
tion that are environmentally relevant. We 
used a more activating basal buffer condi­
tion in these experi  ments to detect both acti­
vating and inhibiting actions of PBDEs on 
RyR activity. Figure 2A shows that BDE­47 
weakly enhanced binding of [3H]Ry to 
Figure 2. Substitution of both para positions with bromine reduces PBDE activity toward RyR1 and RyR2. (A) PBDEs possessing one para-bromine substituent 
(BDE-17, BDE-42, and BDE-49) enhanced [3H]Ry binding to RyR1 microsomes in a concentration-dependent manner (maximum of 446% for BDE-17, 206% for 
BDE-42, and 527% for BDE-49 compared with vehicle); in contrast, BDE-47, with two para-bromine substituents, showed significantly lower efficacy (maximum of 
145% compared with vehicle). (B) SAR for PBDEs (each at 10 µM) as assessed using [3H]Ry binding analysis of microsomes enriched in RyR2; n = 3 or 4 indepen-
dent experiments, each in triplicate. 
**p < 0.01.
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RyR1 (maximum, ~ 145% of vehicle control 
at 10 µM), whereas BDE­49 and BDE­17 
enhanced binding > 450% relative to vehi­
cle control (EC50 = 2 µM). BDE­42 showed 
intermediate activity (250% of vehicle control 
at 10 µM) (Figure 2A). A similar SAR was 
observed with RyR2 (Figure 2B). At con­
centrations that maximally enhance RyR1, 
BDE­17 and BDE­49 (10 µM) increased 
[3H]Ry binding to RyR2 by approximately 
300%, whereas BDE­42 was intermediate 
(200%), and BDE­47 had negligible activity. 
A similar SAR was identified with [3H]Ry   
binding to cortical membrane prepara­
tions that contain a mixture of RyR1 and 
RyR2 [see Supplemental Material, Figure 1 
(doi:10.1289/ehp.1002728)]. Collectively, 
these data indicate that in addition to two 
ortho­bromines, one unsubstituted para posi­
tion is critical for enhancing RyR activity.
Para-methoxy diminishes but does not 
elimi  nate RyR1 activity. To further test the 
hypothe  sis that the para substitution is an 
important determinant of RyR activity, we 
examined the activity of para-methoxy metabo­
lites using [3H]Ry binding and Ca2+ flux analy­
ses of RyR1. Addition of a methoxy substituent 
at the 4 or 4´ positions of BDE­17, BDE­42, 
or BDE­49 significantly reduced the apparent 
efficacy by > 2­fold in [3H]Ry binding experi­
ments [see Supplemental Material, Figure 2A 
(doi:10.1289/ehp.1002728)]. However, addi­
tion of methoxy to the 5 position of BDE­47 
did not alter activity toward RyR1. Addition of 
BDE­49 (10 µM) subsequent to loading vesi­
cles with Ca2+ in the presence of ATP elicited a 
very robust efflux of the accumulated Ca2+, and 
the release could be completely blocked by the 
RyR channel blocker RR (see Supplemental 
Material, Figure 2B, top). 4´­Methoxylated­
BDE­49 (10 µM) added to the Ca2+­loaded 
vesicles under identical assay conditions elicited 
a much slower release of Ca2+ than the parent 
congener, and these effects were blocked by 
RR (see Supplemental Material, Figure 2B, 
middle). In contrast, BDE­47 (10 µM) did not 
sufficiently sensitize RyR1 to produce net Ca2+ 
efflux from the vesicles in the presence of the 
strong SERCA pump activity present in this 
assay (see Supplemental Material, Figure 2B, 
bottom). 
Rapamycin pretreatment selectively 
negates PCB-49–induced Ca2+ release. As 
predicted by results with BDE­4 (Figure 1B), 
microsomes preincubated with 20 µM rapamy­
cin or vehicle 2 min before the Ca2+­loading 
phase greatly diminished subsequent response 
to BDE­49 (2 µM). However, regardless of 
the pretreatment protocol, the RyR1 chan­
nels remained responsive to 4­CmC [see 
Supplemental Material, Figure 3 (doi:10.1289/
ehp.1002728)].
Hydroxylation can differentially influ-
ence PBDE activity toward RyR1. OH­BDE 
metabo  lites have been found in maternal and 
fetal blood (Qiu et al. 2009); therefore, we 
tested the activity of the environ  mentally rele­
vant hydroxylated metabo  lites 6­OH­BDE­47 
and 4´­OH­BDE­49 toward RyR1 using [3H]
Ry binding analysis (Figure 3A). Unexpectedly, 
4´­OH­BDE­49 exhibited a non  monotonic 
concentration–effect relationship, activating 
RyR1 at approximately 350% of vehicle control 
at 5 µM but having reduced efficacy at higher 
concentrations (< 200% of vehicle control at 
10 µM). Interestingly, 6­OH­BDE­47 inhibited 
[3H]Ry binding in a concentration­dependent 
manner, with complete inhibition observed at 
10 µM (Figure 3A). Because the rate of [3H]Ry 
binding to RyRs is too slow to detect transient 
activation of RyR1 if it occurred, we proceeded 
to test whether 6­OH­BDE­47 had tempo­
rally distinct actions, initially activating and 
subsequently blocking RyR1 channel activity, 
by measuring the actions of this congener on 
microsomal Ca2+ fluxes. Indeed, microsomal 
vesicles rapidly released their accumulated Ca2+ 
when acutely challenged with 6­OH­BDE­47 
(10 µM), and this effect was completely blocked 
by RR (Figure 3B). In addition, microsomal 
vesicles preincubated with 6­OH­BDE­47 at 
37°C (< 2 hr) significantly inhibited 4­CmC–
induced Ca2+ release (Figure 3C), indicating 
that prolonged incubation does subsequently 
block RyR1, as predicted from [3H]Ry binding 
studies (Figure 3A).
Nanomolar BDE-49, but not BDE-47, 
sensitizes RyR-mediated Ca2+release in intact 
cells. To determine whether the different effi­
cacies of BDE­47 and BDE­49 toward RyRs 
extend to RyR­dependent signaling events in 
intact cells, we tested the activity of the two 
congeners toward HEK293null cells (which 
lack any expression of RyRs) and HEK293 
cells, which stably express either RyR1 
(HEK293RyR1) or RyR2 (HEK293RyR2) 
[see Supplemental Material, Figure 4A,D 
(doi:10.1289/ehp.1002728)]. Cells of each 
geno  type were pretreated with 250 nM 
BDE­49 or BDE­47 for 16 hr before loading 
them with the Ca2+­sensitive dye Fluo­4. Once 
loaded with Ca2+ indicator, cells were imaged 
to detect changes in cytoplasmic Ca2+ ([Ca2+]i) 
before and after challenge with RyR agonists 
caffeine or 4­CmC (Fessenden et al. 2000). 
HEK293RyR1 responded to brief (10­sec) focal 
application of caffeine with a Ca2+ transient 
whose amplitude was concentration dependent 
Figure 3. Complex activity of 6-OH-BDE-47 and 4´-OH-BDE-49 toward RyR1. (A) [3H]Ry binding analysis 
under equilibrium conditions (3 hr at 37°C) indicates that 6-OH-BDE-47 inhibits RyR1, whereas 4´-OH-
BDE-49 alters [3H]Ry binding in a nonmonotonic manner (n = 3 independent experiments in triplicate). 
(B) Microsomal vesicles actively loaded with Ca2+ release their accumulated Ca2+ when acutely chal-
lenged with 6-OH-BDE-47 (10 µM), whereas RR (1 µM) blocked 6-OH-BDE-47–induced Ca2+ release (n = 3). 
(C) Preincubation (> 30 min) with 6-OH-BDE-47 significantly attenuates 4-CmC (1 mM)-induced Ca2+ release 
from microsomes (n = 3).
**p < 0.01. 
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(see Supplemental Material, Figure 4B). 
Pretreatment of HEK293RyR1 cells with 
BDE­49 enhanced caffeine­induced Ca2+ 
release, resulting in larger transient amplitudes 
than vehicle control (p < 0.05) at lower caffeine 
concentrations (see Supplemental Material, 
Figure 4B,C). In contrast, BDE­47 did not 
alter caffeine responses compared with vehicle 
control. HEK 293null cells failed to respond 
to RyR1 agonists even when pretreated 
with BDE­49 (see Supplemental Material, 
Figure 4B). HEK293RyR2 cells responded vig­
orously to a brief puff of 4­CmC (1 mM) in 
contrast to HEK293null cells (see Supplemental 
Material, Figure 4E). HEK293RyR2 cells 
pretreated for 16 hr with BDE­49, but not 
BDE­47, showed significantly larger Ca2+ 
transient amplitudes (~ 180%; p < 0.05) com­
pared with vehicle controls (see Supplemental 
Material, Figure 4F).
RyR activity predicts neurotoxic poten-
tial. Considering the widely divergent activi­
ties of BDE­47 and BDE­49 on RyR1 and 
RyR2, both of which are expressed in brain, 
we tested whether their differential effects on 
RyR activity predict neuro  toxicity. First, we 
examined how these PBDEs influence spon­
taneous electrical spiking activity of cortical 
neurons cultured on microelectrode arrays 
(MEA). MEAs have been used increasingly to 
assess altered develop  ment of neural networks 
and excito  toxicity caused by xeno  biotics 
(Johnstone et al. 2010). Cortical neurons cul­
tured on MEA probes exhibited spontaneous 
spike (action potential) activity at 21 days 
in vitro (Figure 4A,B). Sequential exposure to 
increasing concentrations of BDE­49 (0, 0.2, 
20, and 200 nM) at 10­min intervals signif­
icantly increased the number of spontane­
ous spikes, whereas BDE­47 (< 200 nM) did 
not alter spike activity relative to the control 
period (Figure 4B,C).
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Figure 4. Cortical neurons show excitoxicity to BDE-49 and 6-OH-BDE-47, 
but not BDE-47. (A) Primary cultured rat cortical neurons on MEA (21 days 
in vitro); bar = 100 µm. (B) Representative raster plot of spike trains over 
a 6-sec period in neurons exposed acutely to vehicle, BDE-47, or BDE-49. 
(C) BDE-49, but not BDE-47, increases spontaneous spike activity in a 
concentration-dependent manner; data are presented as mean ± SE 
(n = three arrays per treatment group). (D) Micrographs of neurons after 
48 hr exposure to vehicle, BDE-47 (10 µM), or BDE-49 (5 µM or 10 µM) 
between 6 and 8 days in vitro. Compared with neurons exposed to vehicle 
and BDE-47, BDE-49–exposed neurons showed pronounced morpho-
logical changes, including fasciculation and decreased soma diameter; 
bar = 150 µm. (E) BDE-49 (5 and 10 µM) and 6-OH-BDE-47 (10 µM), but 
not BDE-47, significantly decreased cell viability as assessed using the 
MTS assay. 
*p < 0.05 compared with vehicle control by ANOVA with post hoc Tukey’s test. 
**p < 0.01.Kim et al.
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We next determined whether exposures 
to BDE­47 and BDE­49 at higher concentra­
tions (low micromolar) and for longer times 
(48 hr) influence the viability of cortical neu­
ron cultures. Compared with vehicle controls, 
cultures exposed to 5 and 10 µM BDE­49 
invariably showed loss of phase­bright cell 
bodies, decreased soma diameter, extreme fas­
ciculation of processes, and a tendency for 
the monolayer to pull up off the substrate 
(Figure 4D). In contrast, no overt morpho­
logical abnormalities were observed in neu­
rons exposed to BDE­47 (5 µM, 48 hr). Cell 
viability assessed using the MTS assay con­
firmed that BDE­49 (> 5 µM) significantly 
decreased neuronal cell viability by > 50% 
(p < 0.05). A potentially significant finding 
is that 6­OH­BDE­47 (10 µM), a major 
metabo  lite of BDE­47, also caused significant 
loss of cell viability (Figure 4E).
Discussion
The relatively high levels of PBDEs recently 
meas  ured in young children in North 
America (Herbstman et al. 2010), and espe­
cially California (Rose et al. 2010), esca­
lates concerns about their effects on human 
and environmental health that were raised 
a decade ago (Darnerud et al. 2001). Levels 
of the most abundant congeners in serum—
BDE­47, BDE­99, and BDE­100—in chil­
dren < 72 months of age have been reported 
to be associated with lower scores on tests of 
cognitive, behavioral, and physical develop­
ment (Herbstman et al. 2010). PBDE levels   
were also correlated with impairments in 
fine psycho  motor abilities and attention but 
improved coordination, visual perception, and 
behavior (Roze et al. 2009). Similarly, in utero 
or post  natal exposure to PBDEs resulted in 
hyper  activity in rats (Kuriyama et al. 2005; 
Suvorov et al. 2009) and mice (Viberg et al. 
2004). Exposure to PBDEs in neonatal mice 
resulted in learning deficits in visual discrimi­
nation tasks (Dufault et al. 2005).
Despite the mounting evidence that 
PBDEs cause developmental neurotoxicity, 
the principal molecular targets responsible for 
this toxicity have not been identified. PBDEs 
are usually found in combination with other 
persistent organic pollutants such as PCBs, tri­
closan, and o,p´­DDE (o,p´­dichloro  diphenyl­
dichloro  ethylene), each of which has been 
shown to alter Ca2+ homeo  stasis, in part by 
dys  regu  lating RyR channels (Ahn et al. 2008; 
Morisseau et al. 2009; Pessah et al. 2010). 
RyRs, along with inositol 1,4,5­trisphosphate 
receptors (IP3Rs), are a family of Ca2+ chan­
nels in endoplasmic or sarco  plasmic reticu­
lum, broadly expressed in both excitable cells 
(striated muscles, neurons) and non  excitable 
cells (dendritic cells, T lympho  cytes) (Pessah 
et al. 2010). RyRs assemble as very large 
homo  tetrameric structures with a molecular 
weight > 2 MDa and consist of a very large 
cytoplasmic assembly (the foot region) and a 
relatively small trans  membrane assembly com­
posed of six putative transmembrane passes 
with a central ion­conducting pore. All three 
isoforms of RyRs are expressed in the central 
nervous system but are differentially distrib­
uted among specific brain regions, cell types, 
and cell regions, reflecting their participation 
in specialized functions (Pessah et al. 2010). 
Environmental toxicants that have a poten­
tial for altering RyR function can influence 
neuronal excitability, alter synaptic plasticity, 
and activate cytosolic and nuclear transcrip­
tional events implicated in activity­dependent   
dendritic growth (Pessah et al. 2010).
The SAR of PBDEs toward RyR1 and 
RyR2 indicate that the location of ortho­ and 
para-bromine substituents significantly influ­
ence the level of activation of RyRs, as high­
lighted by divergent activities of BDE­47 and 
BDE­49, and is unrelated to differences in 
lipophilicity. In this regard, the free concen­
tration of BDE­49 is likely to be significantly 
lower than those added to the assays used 
in this study. This aspect of SAR is similar 
to that observed with the influence of para­
chlorines on PCB activity toward RyR1 and 
RyR2 (Pessah et al. 2006). In this respect, 
the larger bromine substitution at the para 
positions more dramatically reduces PBDE 
activity than the corresponding chlorine sub­
stitutions on PCBs and may be because of 
steric inter  ference. The similarity in structure–
activities with ortho and para substitutions sug­
gests a common mechanism for their effects 
on RyR activity. In support of a convergent 
mechanism, the activity of PCBs, bastadins, 
and PBDEs toward RyR1 can be selectively 
eliminated by using rapamycin to disrupt the 
RyR1­FKBP12 complex (Chen et al. 1999; 
Pessah et al. 2006; Wong and Pessah 1997), 
an accessory protein important in fine­tun­
ing the gating properties of RyR1 channels 
(Brillantes et al. 1994).
The results from the present study show­
ing that 6­OH­BDE­47 produces temporally 
defined biphasic actions on microsomal Ca2+ 
release is consistent with results obtained by 
Dingemans et al. (2008) showing that acute 
exposure of PC12 cells to 6­OH­BDE­47 
promotes Ca2+ release from intra  cellular Ca2+ 
stores. [3H]Ry binding analysis reflects the 
activity of RyR channels at steady­state condi­
tions for the radio  ligand (3 hr) and apparently 
fails to detect the initial channel activation elic­
ited by 6­OH­BDE­47. However Ca2+ flux 
measurements clearly show that the immediate 
actions of this congener are activation of RyR1 
and release of Ca2+ accumulated in microsomal 
vesicles, whereas prolonged exposure signifi­
cantly attenuates 4­CmC–  induced Ca2+ release. 
Our results reveal that OH­PBDEs have com­
plex biphasic actions on RyR function and 
SR/ER Ca2+ transport properties that depend 
not only on the local concentration but also on 
the length of the exposure.
The complex interactions of OH­BDEs 
leading to activation or inhibition of RyR1 
channels appear to mirror the complex SAR 
described with naturally occurring macro  cyclic 
bromo  tyrosine toxins from Ianthella basta, 
termed “bastadins” (Chen et al. 1999; Mack 
et al. 1994). The reduced toxicophore that 
confers RyR activity resides within the eastern 
and western non  coplanar bromo  catechol ether 
moieties that resemble OH­BDE (Masuno 
et al. 2006). The bromine and hydroxyl sub­
stituents about the diphenylether can result in 
either channel activation or channel inhibition.
Our results with OH­BDEs suggest an 
under  lying mechanism for the results reported 
by Dingemans et al. (2008, 2010), who iden­
tified a number of 4­OH, 5­OH, and 6­OH 
metabolites of BDE­47 and BDE­49 that at 
5–20 µM were more potent at mobilizing 
Ca2+ from ER and/or mitochondrial stores 
than their respective parent structures when 
applied to unstimulated (resting) PC12 cells. 
A high concentration of BDE­47 (20 µM) 
enhanced the Ca2+ transient amplitude trig­
gered by bolus addition of extra  cellular K+, 
whereas other PBDE congeners lacked sig­
nificant influence (Dingemans et al. 2010). 
Interestingly hydroxylation at the 4, 5, and 
6 positions of BDE­47 or BDE­49 (2–20 µM) 
significantly inhibited depolarization­triggered 
Ca2+ transient amplitude. These previously 
reported effects of PBDEs and OH­PBDEs 
could be explained, at least in part, by their 
actions on RyR channels as we describe 
here. Sensitization of RyRs in resting cells by 
OH­PBDEs could result in chronic Ca2+ leak­
age and depletion of ER stores. This could 
account in large part for both the rapid and 
delayed rises in cyto  plasmic Ca2+ previously 
observed by Dingemans et al. (2008, 2010). 
The suppression of the Ca2+ transient ampli­
tude triggered by depolarization subsequent 
to 20 min pretreatment with 2 and 20 µM 
OH­PBDE (Dingemans et al. 2010) would 
be expected to cause partial or complete deple­
tion of ER stores as a direct consequence of 
sub  maximal or maximal activation of RyR 
channels, respectively. Interestingly, 4­OH­
BDE­49 shows a non  monotonic concentra­
tion–response relationship toward RyR1. In 
contrast, BDE­49 is a very efficacious activator 
of RyRs in [3H]Ry binding studies, potently 
sensitizes caffeine­ or 4­CmC–triggered Ca2+ 
release in HEK293 cells that express RyRs, 
and is a potent excito  toxicant toward primary 
cortical neurons. In this regard, 48 hr exposure 
to BDE­47 < 10 µM does not promote loss 
of neuronal viability, whereas BDE­49 does. 
These observations are apparently at odds 
with reports that developmental exposure to 
BDE­47 causes developmental neuro  toxicity PBDEs dysregulate ryanodine receptors
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in rodent models (Dingemans et al. 2007; 
Suvorov et al. 2009). One interpretation of 
this discrepancy is that RyR­independent 
mechanisms mediate the adverse effects of 
BDE­47 on the developing nervous system. 
An alternative suggestion supported by our 
data is that the neuro  toxic effects of BDE­47 
observed in vivo are mediated by 6­OH­
BDE­47 rather than the parent congener; 
the lack of effect of the parent compound on 
either spontaneous activity or cell viability in 
cultured cortical neurons reflects the limited 
metabolic capacity of this in vitro model.
The present study indicates that [3H]Ry   
binding studies are a rapid means of defining 
SARs that predict neuro  toxic PBDEs, much 
like its use to identify neuro  toxic PCBs (Pessah 
et al. 2010). The toxicological significance of 
these findings is illustrated by a recent report 
by (Miller et al. 2009) that BDE­49, which 
is not typically measured in human samples, 
was detected in gestational tissues from women 
in southeast Michigan at levels comparable 
with BDE­47. BDE­49 comprised 17% of 
the total PBDE concentration in these tissues. 
This observation is consistent with reports 
identifying BDE­49 as a major contributor 
to PBDE load in fish (Mariottini et al. 2008; 
Roosens et al. 2008), including one study of 
Great Lakes fish that identified BDE­49 as the 
most abundant congener (Manchester­Neesvig 
et al. 2001). The mechanisms contributing to 
this apparent selective enrichment of BDE­49 
have yet to be determined, but as discussed by 
Miller et al. (2009), these findings suggest that 
the majority of human studies under  estimate 
PBDE levels by as much as 14–19%. Our 
studies suggest that the problem is even greater, 
in that most exposure studies fail to account 
for congeners that pose significant risk to the 
developing nervous system. The SAR defined 
in our study provides a tool for refining human 
exposure studies to focus on those PBDE con­
geners with the greatest neuro  toxic potential.
Conclusions
The present study is the first to identify RyR1 
and RyR2 as direct targets of both PBDEs and 
their hydroxylated metabolites. These results are 
significant because RyRs are broadly expressed 
in excitable and non  excitable cells, where they 
regulate key physiological and patho  physio­
logical functions (Pessah et al. 2010). Certain 
PBDEs and their hydroxylated metabolites 
have potent (maximum activities < 10 µM) 
and high efficacies toward altering the activities 
of RyR1 and RyR2 channels, and these same 
PBDEs are found in maternal and fetal blood, 
and human gestational tissues (Miller et al. 
2009; Qiu et al. 2009) as well as in animal 
tissues (Marsh et al. 2004; Qiu et al. 2007; 
Valters et al. 2005). In addition, the known 
contribution of RyRs to inherited and acquired 
disorders (Pessah et al. 2010) strongly suggests 
that Ca2+ signaling dys  regulation mediated by 
RyR channel mecha  nisms should be included 
in assessments of risk. 
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